Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| DPRIT Seed Grant | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to demonstrate feasibility, usability, and acceptability of VR-based cognitive and physical rehabilitation, evaluate adherence, tolerability, and fidelity to the VR intervention and explore preliminary effectiveness of VR-based rehabilitation on cognitive, physical, and functional outcomes
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| VR sessions | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VR sessions | Device | Participants will complete 3 supervised VR sessions using the Real System™ VR headset, per week for 6 weeks, for a total of 18 sessions. Each session will last approximately 60 minutes, with time allocated for setup and brief symptom checks |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility as assessed by the recruitment rate | from baseline to end of intervention (6 weeks) | |
| Feasibility as assessed by the retention rate | from baseline to end of intervention (6 weeks) | |
| Feasibility as assessed by the session completion rate | from baseline to end of intervention (6 weeks) | |
| Usability as assessed by the System Usability Scale (SUS) | The System Usability Scale (SUS) is a validated 10-item questionnaire used to assess participants' perceived usability of the intervention. each rated on a 5-point Likert scale from 1 = Strongly Disagree, 2 = Disagree 3 = Neutral ,4 = Agree, 5 = Strongly Agree. Scores range from 0 to 100, with higher scores indicating greater usability. | Post-intervention only (Final visit at 6 weeks) |
| Acceptability / Presence as assessed by the Presence Questionnaire (PQ) | This is a 29 item questionnaire, each is scored on a seven-point Likert-type scale with a score range form 29-203. Higher scores indicate a greater sense of presence or immersion in the virtual environment. | Post-intervention only (Final visit at 6 weeks) |
| Tolerability / Side Effects as assessed by the Simulator Sickness Questionnaire (SSQ) | This is a 16 item questionnaire and each is scored form 0(none) to 3(severe). Scores are combined using weighted subscales to generate a total score, with higher scores indicating greater simulator sickness | Before + immediately After each VR session |
| Adherence / Engagement as assessed by the session attendance as entered in VR system logs |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Seema S Aggarwal, PhD, APRN, AGNP-C | Contact | (713) 500-9946 | Seema.S.Aggarwal@uth.tmc.edu | |
| Tela Todd | Contact | (713) 500-7039 | Tela.Todd@uth.tmc.edu |
| Name | Affiliation | Role |
|---|---|---|
| Seema Aggarwal, PhD, APRN, AGNP-C | The University of Texas Health Science Center, Houston | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Post-intervention only (Final visit at 6 weeks) |
| Adherence / Engagement as assessed by the time from start to end of VR session as entered in VR system logs | Post-intervention only (Final visit at 6 weeks) |
| Adherence / Engagement as assessed by the number of repetitions of the activity as indicated by device metrics | Post-intervention only (Final visit at 6 weeks) |
| ID | Term |
|---|---|
| D060825 | Cognitive Dysfunction |
| ID | Term |
|---|---|
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided